These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4160834)

  • 21. [Is a cure possible for primary state-I endometrial cancer using drug therapy?].
    Bokhman IaV; Chepik OF; Volkova AT; Vishnevskiĭ AS
    Vopr Onkol; 1982; 28(3):34-42. PubMed ID: 7064417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of long-term progestational treatment on the course of endometrial adenocarcinoma].
    Szarvas Z
    Morphol Igazsagugyi Orv Sz; 1978 Jul; 18(3):166-73. PubMed ID: 714054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestogens in the treatment of carcinoma of the endometrium.
    Kennedy BJ
    Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
    [No Abstract]   [Full Text] [Related]  

  • 24. Progestogen treatment of recurrent endometrial carcinoma.
    Malkasian GD; Decker DG; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1971 May; 110(1):15-23. PubMed ID: 5573604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of progesterone in human endometrial cancer.
    Kelley RM; Baker WH
    Cancer Res; 1965 Aug; 25(7):1190-2. PubMed ID: 5843268
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
    Bochmann JW
    Zentralbl Gynakol; 1981; 103(21):1289-93. PubMed ID: 7324631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1964 Jan; 23():51-62. PubMed ID: 14110061
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of progestational agents in treatment of endometrial carcinoma.
    Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
    Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
    Stertmann WA; Hocke M; Röttger P
    MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
    [No Abstract]   [Full Text] [Related]  

  • 32. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the therapy of metastases of uterine adenocarcinoma].
    Poggi G
    Minerva Ginecol; 1969 Sep; 21(18):1189-92. PubMed ID: 5402128
    [No Abstract]   [Full Text] [Related]  

  • 34. [Description of some cases of mammary and uterine carcinoma treated with hydroxyprogesterone capronate].
    Barnaba T
    Minerva Ginecol; 1970 Oct; 22(19):957-63. PubMed ID: 5515156
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormonal treatment of endometrial carcinoma.
    Nilsen PA
    Acta Obstet Gynecol Scand; 1969; 48(S3):120-1. PubMed ID: 5380812
    [No Abstract]   [Full Text] [Related]  

  • 37. [Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
    Sharoukhova KS; Vershinina GN; Murav'eva NI; Smirnova KD; Goncharova MG
    Akush Ginekol (Mosk); 1970 Oct; 46(10):9-13. PubMed ID: 5519750
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
    Ohta M; Takeda A; Ninagawa T; Tomoda Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptosis as a criterion for sensitivity of uterine cervical adenocarcinoma to cisplatin.
    Sekiguchi I; Suzuki M; Ohwada M; Sato I
    Oncol Rep; 1998; 5(5):1077-8. PubMed ID: 9683811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. II. Influence on carbohydrate metabolism].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1624-31. PubMed ID: 5373231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.